Back
LLY
Description
Description
Eli Lilly and Company is engaged in drug manufacturing businesses. The Company discovers, develops, manufactures, and markets products in the human pharmaceutical products segment. Its diabetes products include Basaglar, Humalog, Humulin, Jardiance, Mounjaro, and Trulicity. Its oncology products consist of Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. Its immunology products include Olumiant and Taltz. Its neuroscience products include Cymbalta, Emgality, and Zyprexa. Its other therapies consist of Bamlanivimab and etesevima...
Show more
NYSE/NASDAQ
Performance
Performance
$903.37
USD
▲ $848.83 (1556.34%)
24th March 2026, 11:58 p.m.
1M
10Y
GRAPH
TABLE
GRAPH
TABLE
* US price history does not take into account stock splits
Quick facts
Quick facts
N/A Growth
5 year average annual growth
N/A
5 year average dividend yield
$15 AUD minimum investment
Due to minimum AUD to USD conversion
$0 USD median portfolio
Median amount held by the community
Costs
Costs
PURCHASE FEE
$6.50 AUD (or $5.50 with Pearler Prepay)
MANAGEMENT FEE
N/A
Community insights
Community insights
General statistics
0 investors hold LLY
N/A average time between investments
N/A average holding per investor
1055 days since last community investment
Demographics
Income of investors
Less than 50k
-
50k - 100k
-
100k - 150k
-
150k - 200k
-
More than 200k
-
Age of investors
18-25 years old
-
26-34 years old
-
35-90 years old
-
Legal gender of investors
0% male
0% female
Related items
Related items
Pricing data reflects the most recent end-of-day traded price. Live pricing is shown at the time of buy/sell and may differ from what's displayed here. Other data is provided by our data partner, last updated on Wed Mar 25 2026, and may have changed since.
Learn more
Learn more
How your home impacts your net worth in Australia
READ
Long-term investing
Home ownership
Your house can boost your net worth on paper – but what does that really mean in practice?
3 January 2026
・
Hayden Smith
・
6 min read
0 likes
・
0 views
What are the potential pros and cons of using margin to boost ETF returns?
READ
Long-term investing
Are you looking to learn the potential pros and cons of using margin to boost ETF returns? Well, we have some REALLY goo...
28 August 2025
・
Nick Nicolaides
・
5 min read
0 likes
・
0 views
US stock
ASK & ANSWER
Shares & crypto
What are the best tech stocks to invest now in the US market?
K-Investor
•
July 27th, 2022
1 like
・
0 views
・
AU vs US shares
ASK & ANSWER
First-time investor
Hi, I’m fairly new to investing and this is a dumb question but what is the difference when investing in the AU shares v...
Molly Pearse
•
January 29th, 2023
3 likes
・
0 views
・
Aus v US shares - smart to invest in both?
ASK & ANSWER
Choosing Investments
I currently hold shares in various Australian ETFs including VDHG, NDQ, ETHI, etc. My question is whether I should also ...
Stephanie Varga
•
May 16th, 2023
2 likes
・
1 view
・